VOYAGER THERAPEUTICS INC's ticker is and the CUSIP is 92915B906. A total of 4 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13 | -96.4% | 1,700 | -94.7% | 0.00% | – |
Q2 2023 | $365 | +60.1% | 31,900 | +7.4% | 0.00% | – |
Q1 2023 | $228 | +62.9% | 29,700 | +28.6% | 0.00% | – |
Q4 2022 | $140 | -100.0% | 23,100 | -87.1% | 0.00% | -100.0% |
Q3 2022 | $1,059,000 | +7.8% | 178,900 | +7.6% | 0.00% | 0.0% |
Q2 2022 | $982,000 | +25.7% | 166,200 | +62.0% | 0.00% | 0.0% |
Q1 2022 | $781,000 | +529.8% | 102,600 | +123.0% | 0.00% | – |
Q4 2021 | $124,000 | +254.3% | 46,000 | +422.7% | 0.00% | – |
Q3 2021 | $35,000 | -2.8% | 8,800 | 0.0% | 0.00% | – |
Q2 2021 | $36,000 | +56.5% | 8,800 | +17500.0% | 0.00% | – |
Q1 2021 | $23,000 | +4.5% | 50 | +61.3% | 0.00% | – |
Q4 2020 | $22,000 | +100.0% | 31 | +181.8% | 0.00% | – |
Q3 2020 | $11,000 | -73.8% | 11 | -67.6% | 0.00% | – |
Q2 2020 | $42,000 | +31.2% | 34 | -2.9% | 0.00% | – |
Q1 2020 | $32,000 | -84.9% | 35 | -77.0% | 0.00% | – |
Q4 2019 | $212,000 | -40.9% | 152 | -27.3% | 0.00% | -100.0% |
Q3 2019 | $359,000 | +160.1% | 209 | +309.8% | 0.00% | – |
Q2 2019 | $138,000 | +2660.0% | 51 | +1600.0% | 0.00% | – |
Q1 2019 | $5,000 | 0.0% | 3 | -50.0% | 0.00% | – |
Q4 2018 | $5,000 | -80.8% | 6 | -57.1% | 0.00% | – |
Q3 2018 | $26,000 | -40.9% | 14 | -39.1% | 0.00% | – |
Q2 2018 | $44,000 | +340.0% | 23 | -36.1% | 0.00% | – |
Q1 2018 | $10,000 | – | 36 | +1700.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 2 | -95.6% | 0.00% | – |
Q3 2017 | $8,000 | – | 45 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 24,100 | $304,000 | 0.00% |
SIMPLEX TRADING, LLC | 34 | $42,000 | 0.00% |
JPMORGAN CHASE & CO | 59,300 | $748,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |